封面
市場調查報告書
商品編碼
1322993

患者登記軟體的全球市場

Patient Registry Software

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球患者登記軟體市場將達到 34 億美元

在 COVID-19 後商業環境發生變化的情況下,全球患者登記軟體市場預計到 2022 年將達到 14 億美元,預計到 2030 年將達到 34 億美元,2022 年至 2030 年年複合成長率預計為11.7 %。產品註冊是本報告分析的細分市場之一,預計年複合成長率11%,到分析期結束時將達到 9.054 億美元。鑑於大流行後的持續復甦,醫療保健註冊領域的成長將在未來八年以 11.2% 的年複合成長率重新調整。

美國市場預計為 4.111 億美元,中國預計年複合成長率為 11%

2022 年美國患者登記軟體市場預計將達到 4.111 億美元。中國作為世界第二大經濟體,預計到2030年市場規模將達到5.756億美元,2022年至2030年的分析期間年複合成長率為11%。其他值得注意的地域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 10.5% 和 9.9%。在歐洲,德國預計年複合成長率約為 8.4%。

受訪企業示例

  • Dacima Software, Inc.
  • Evado Pty. Ltd.
  • FIGmd, Inc.
  • Global Vision Technologies, Inc.
  • Ifa Systems AG
  • Imagetrend, Inc.
  • Liaison Technologies
  • M2S, Inc.
  • McKesson Corporation
  • Optum, Inc.
  • Velos, Inc.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP13881

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Patient Registry Software Market to Reach $3.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Patient Registry Software estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$3.4 Billion by 2030, growing at aCAGR of 11.7% over the period 2022-2030. Product Registries, one of the segments analyzed in the report, is projected to record 11% CAGR and reach US$905.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Health Service Registries segment is readjusted to a revised 11.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $411.1 Million, While China is Forecast to Grow at 11% CAGR

The Patient Registry Software market in the U.S. is estimated at US$411.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$575.6 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Select Competitors (Total 42 Featured) -

  • Dacima Software, Inc.
  • Evado Pty. Ltd.
  • FIGmd, Inc.
  • Global Vision Technologies, Inc.
  • Ifa Systems AG
  • Imagetrend, Inc.
  • Liaison Technologies
  • M2S, Inc.
  • McKesson Corporation
  • Optum, Inc.
  • Velos, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Patient Registry Software - Global Key Competitors Percentage Market Share in 2020 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Product Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Health Service Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Disease Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Hospitals & Medical Practices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Pharma, Biotech & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Government Organizations & TPAs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Patient Registry Software Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: China 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: China 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: France 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: France 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2023 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION